相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
PubChem in 2021: new data content and improved web interfaces
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2021)
The Impact of Genetic Polymorphisms in Organic Cation Transporters on Renal Drug Disposition
Zulfan Zazuli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Interaction of rs316019 variants of SLC22A2 with metformin and other drugs- an in silico analysis
Abu Ashfaqur Sajib et al.
JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY (2018)
CHARMM36m: an improved force field for folded and intrinsically disordered proteins
Jing Huang et al.
NATURE METHODS (2017)
Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A MetGen Meta-Analysis
T. Dujic et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field
Jumin Lee et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
SIFT missense predictions for genomes
Robert Vaser et al.
NATURE PROTOCOLS (2016)
Metformin-associated lactic acidosis: Current perspectives on causes and risk
Ralph DeFronzo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Pharmacogenetic studies update in type 2 diabetes mellitus
Shalini Singh et al.
WORLD JOURNAL OF DIABETES (2016)
Single nucleotide polymorphisms of the SLC22A2 gene within the Xhosa population of South Africa
Clifford Jacobs et al.
DRUG METABOLISM AND PHARMACOKINETICS (2015)
Adverse event notifications implicating metformin with lactic acidosis in Australia
Weiyi Huang et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)
Effect of lifestyle intervention in patients with type 2 diabetes: A meta-analysis
Liang Chen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibition
S. Piel et al.
ACTA PHYSIOLOGICA (2015)
Assessing the local structural quality of transmembrane protein models using statistical potentials (QMEANBrane)
Gabriel Studer et al.
BIOINFORMATICS (2014)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
THE ROLE OF PHARMACOGENETICS IN THE TREATMENT OF DIABETES MELLITUS
Elizabeta Topic
JOURNAL OF MEDICAL BIOCHEMISTRY (2014)
Organic Cation Transporter OCTs (SLC22) and MATEs (SLC47) in the Human Kidney
Hideyuki Motohashi et al.
AAPS JOURNAL (2013)
Influences of Organic Cation Transporter Polymorphisms on the Population Pharmacokinetics of Metformin in Healthy Subjects
Hwa Yoon et al.
AAPS JOURNAL (2013)
Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters
Barbara Gruen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Computational analysis of local membrane properties
Vytautas Gapsys et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin
Mette M. H. Christensen et al.
PHARMACOGENETICS AND GENOMICS (2013)
Genetic Susceptibility to Type 2 Diabetes and Implications for Therapy
Asima Zia et al.
JOURNAL OF DIABETES & METABOLISM (2013)
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. E. Inzucchi et al.
DIABETOLOGIA (2012)
The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization
Sabine Brast et al.
FASEB JOURNAL (2012)
Individualized Therapy for Type 2 Diabetes Clinical Implications of Pharmacogenetic Data
Gaia Chiara Mannino et al.
MOLECULAR DIAGNOSIS & THERAPY (2012)
Reduced catalytic activity of human CYP2C9 natural alleles for gliclazide: Molecular dynamics simulation and docking studies
Hussaina Banu et al.
BIOCHIMIE (2011)
Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients
A. Surendiran et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
Giuliano Ciarimboli et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
CHARMM General Force Field: A Force Field for Drug-Like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields
K. Vanommeslaeghe et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
M. V. Tzvetkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin
Ying Chen et al.
PHARMACOGENETICS AND GENOMICS (2009)
A three-state prediction of single point mutations on protein stability changes
Emidio Capriotti et al.
BMC BIOINFORMATICS (2008)
Interaction of cisplatin with the human organic cation transporter 2
Kelly K. Filipski et al.
CLINICAL CANCER RESEARCH (2008)
Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
I. S. Song et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
Zhi-Jun Wang et al.
PHARMACOGENETICS AND GENOMICS (2008)
Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications
Hermann Koepsell et al.
PHARMACEUTICAL RESEARCH (2007)
I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure
E Capriotti et al.
NUCLEIC ACIDS RESEARCH (2005)
Regulation of organic cation transport
G Ciarimboli et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2005)
Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: A randomized, double-blind, comparative study
F Tosi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance®) in Type 2 diabetic patients inadequately controlled on metformin
M Marre et al.
DIABETIC MEDICINE (2002)
Predicting deleterious amino acid substitutions
PC Ng et al.
GENOME RESEARCH (2001)
Prediction of deleterious human alleles
S Sunyaev et al.
HUMAN MOLECULAR GENETICS (2001)
SNPs, protein structure, and disease
Z Wang et al.
HUMAN MUTATION (2001)
Families of transmembrane sugar transport proteins
MH Saier
MOLECULAR MICROBIOLOGY (2000)
分享论文
